Sharekhan

Valiant Laboratories Ltd

Thu 13/03/2025,15:55:40 | NSE : VALIANTLAB

₹ 80.78-1.87 (-2.26%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 83.07

Previous Close

₹ 82.65

Volume

63033

Mkt Cap ( Rs. Cr)

₹350.99

High

₹ 85.28

Low

₹ 80.00

52 Week High

₹ 171.90

52 Week Low

₹ 79.70

Book Value Per Share

₹ 53.31

Dividend Yield

0.00

Face Value

₹ 10.00

What’s Your Call?

Collective community sentiment on Valiant Laboratories Ltd

Your Vote -

Buy

50.00%

Hold

0.00%

Sell

50.00%

50.00%

2 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

0%

Sell Order Quantity

100%

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Bid Price

Qty

80.78

1254

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

1254

Option Chain

Analyzes market sentiment, predicts Valiant Laboratories Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Valiant Laboratories - Credit Rating

    19 Feb 2025, 11:33AM Valiant Laboratories Limited has informed the Exchange about Credit Rating
  • Valiant Laboratories - Announcement under Regulation 30 (LODR)-Credit Rating

    19 Feb 2025, 11:33AM Announcement under Regulation 30 regarding Credit Ratings issued to the Company
  • Valiant Laboratories - Copy of Newspaper Publication

    8 Feb 2025, 11:58AM Valiant Laboratories Limited has informed the Exchange about Copy of Newspaper Publication
  • Valiant Laboratories - Integrated Filing- Financial

    7 Feb 2025, 8:18PM Integrated Filing (Financials) Report for the quarter ended December 31, 2024
  • Valiant Laboratories - Integrated Filing (Financial)

    7 Feb 2025, 8:15PM Integrated Filing (Financial) Report for the quarter ended December 31, 2024
  • Valiant Laboratories posts Q3 net profit of Rs 1.60 cr

    7 Feb 2025, 6:42PM The company reported standalone net profit during the quarter stood at Rs 1.60 crore compared to net loss of Rs 3.50 crore in the previous year quarte
  • Valiant Laboratories - General Updates

    7 Feb 2025, 5:36PM Valiant Laboratories Limited has informed the Exchange about General Updates
  • Valiant Laboratories - Authorised Persons For Determining / Disclosing Material Events / Information.

    7 Feb 2025, 5:33PM Authorised Persons for Determining/ Disclosing Material Events/ Information.
  • Valiant Laboratories - Financial Result Updates

    7 Feb 2025, 5:29PM Valiant Laboratories Limited has submitted to the Exchange, the financial results for the period ended December 31, 2024.
  • Valiant Laboratories - Financial Results For The Quarter Ended December 31, 2024.

    7 Feb 2025, 5:23PM Financial Results for the quarter ended December 31, 2024.
  • Valiant Laboratories - Outcome of Board Meeting

    7 Feb 2025, 5:17PM Valiant Laboratories Limited has informed the Exchange regarding Outcome of Board Meeting held on February 07, 2025.
  • Valiant Laboratories - Board Meeting Outcome for Outcome Of The Board Meeting Dated February 07, 2025.

    7 Feb 2025, 5:17PM Outcome of the Board Meeting dated February 07, 2025.
  • Valiant Laboratories - Board Meeting Intimation

    31 Jan 2025, 6:02PM VALIANT LABORATORIES LIMITED has informed the Exchange about Board Meeting to be held on 07-Feb-2025 to consider and approve the Quarterly Audited Fin
  • Valiant Laboratories - Board Meeting Intimation for Considering And Approving Audited Standalone And Consolidated Financial R

    31 Jan 2025, 4:25PM Valiant Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/02/2025 ,inter alia, to consider
  • Valiant Laboratories has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2024

    14 Jan 2025, 6:31PM As of December 2024, 74.94% is owned by Indian Promoters and 25.06% by Public. <p align=justify> Top five Promoters holding highest number of shares o
  • Valiant Laboratories - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    8 Jan 2025, 4:11PM Certificate under Reg.74 (5) of SEBI (DP) Regulations, 2018
  • Valiant Laboratories - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    8 Jan 2025, 4:11PM Valiant Laboratories Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
  • Valiant Laboratories - Trading Window-XBRL

    26 Dec 2024, 3:04PM VALIANT LABORATORIES LIMITED has informed the Exchange about Closure of Trading Window
  • Valiant Laboratories - Trading Window

    26 Dec 2024, 3:00PM Valiant Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulati
  • Valiant Laboratories - Shareholder Meeting / Postal Ballot-Scrutinizer\s Report

    20 Dec 2024, 4:13PM Voting Results of the Postal Ballot through remote e-voting along with Scrutinizer's Report
  • Valiant Laboratories - Shareholders meeting

    20 Dec 2024, 4:10PM Valiant Laboratories Limited has submitted the Exchange a copy Srutinizers report of Postal Ballot
  • Valiant Laboratories - Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot

    20 Dec 2024, 4:07PM Voting Results of Postal Ballot through remote e-voting along-with report of the Scrutinizer

Key fundamentals

Evaluate the intrinsic value of Valiant Laboratories Ltd stock 

Name March-24 March-23 March-22
Assets 296.2821 159.89 132.141
Liabilities 296.2821 159.89 132.141
Equity 43.45 32.56 16.28
Gross Profit -8.4083 35.09 42.318
Net Profit 0.3403 28.998 27.496
Cash From Operating Activities 48.7819 22.956 2.251
NPM(%) 0.18 8.68 9.43
Revenue 182.0525 333.91 291.523
Expenses 190.4608 298.82 249.205
ROE(%) 0.14 12.52 11.87

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Valiant Laboratories Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 808.20 -1.14 11.41 46.03 1321.50 1.42
Lotus Eye Hospital and Institute Ltd 57.06 -0.77 237.75 167.72 14.01 0.88
Vaishali Pharma Ltd 12.12 -5.90 606.00 86.45 2.31 0.00
Astec Lifesciences Ltd 653.90 -5.55 0.00 158.15 -239.30 0.00

Company Info

The Company was originally formed as a partnership firm under Indian Partnership Act, 1932, under the name and style of "M/s Bharat Chemicals" pursuant to the deed of partnership dated October 17, 1980. Subsequently, the partnership firm, M/s. Bharat Chemicals was converted into a public limited company under the provisions of the Companies Act with the name "Valiant Laboratories Limited" pursuant to certificate of incorporation dated August 16, 2021 issued by Central Registration Centre, Registrar of Companies. The corporate identity number of the Company is U24299MH2021PLC365904.Key events and milestones :1980- Formed M/s. Bharat Chemicals (a partnership firm)1981- Acquired plot No. L-30 in the Tarapur Industrial Area, Palghar, Maharashtra on leasehold basis admeasuring about 1,000 sq. mtrs1982- Commenced manufacture of Paracetamol2004-05- Acquired additional Plot Nos. L-28, L-28 (part), L-29 and L-13 at Tarapur Industrial Area, Palghar, Maharashtra collectively admeasuring about 3,000 sq.mtrs2015- The annual revenue from operations crossed Rs.500 million2021- Converted from partnership firm into a public limited company- The annual revenue from operations crossed Rs.1,000 million2022- The annual revenue from operations crossed Rs.2,000 million- Formed the wholly owned subsidiary, VASPL to diversify the business activities

The Company was originally formed as a partnership firm under Indian Partnership Act, 1932, under the name and style of "M/s Bharat Chemicals" pursuant to the deed of partnership dated October 17, 1980. Subsequently, the partnership firm, M/s. Bharat Chemicals was converted into a public limited company under the provisions of the Companies Act with the name "Valiant Laboratories Limited" pursuant to certificate of incorporation dated August 16, 2021 issued by Central Registration Centre, Registrar of Companies. The corporate identity number of the Company is U24299MH2021PLC365904.Key events and milestones :1980- Formed M/s. Bharat Chemicals (a partnership firm)1981- Acquired plot No. L-30 in the Tarapur Industrial Area, Palghar, Maharashtra on leasehold basis admeasuring about 1,000 sq. mtrs1982- Commenced manufacture of Paracetamol2004-05- Acquired additional Plot Nos. L-28, L-28 (part), L-29 and L-13 at Tarapur Industrial Area, Palghar, Maharashtra collectively admeasuring about 3,000 sq.mtrs2015- The annual revenue from operations crossed Rs.500 million2021- Converted from partnership firm into a public limited company- The annual revenue from operations crossed Rs.1,000 million2022- The annual revenue from operations crossed Rs.2,000 million- Formed the wholly owned subsidiary, VASPL to diversify the business activities

Read More

Parent Organisation

Valiant Laboratories Ltd.

Founded

06/08/2021

Managing Director

Mr.Santosh S Vora

NSE Symbol

VALIANTLABEQ

FAQ

The current price of Valiant Laboratories Ltd is ₹ 80.78.

The 52-week high for Valiant Laboratories Ltd is ₹ 85.28 and the 52-week low is ₹ 80.00.

The market capitalization of Valiant Laboratories Ltd is currently ₹ 350.99. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Valiant Laboratories Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Valiant Laboratories Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Valiant Laboratories Ltd shares.

The CEO of Valiant Laboratories Ltd is Mr.Santosh S Vora, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT